Clinical trial · Observational
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
A Prospective Study on the Factors Sustaining Tobacco Abstinence in Patients Treated With Radio-chemotherapy or Radiotherapy Alone for Head and Neck or Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Nicotine Addiction | — | UNRESOLVED | — |
| Nicotine Dependence | — | UNRESOLVED | — |
| Smoking | — | UNRESOLVED | — |
| Smoking Cessation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemoradiotherapy or radiotherapy alone | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Abstinence at 1 month and 6 months after the end of treatment
- timeFrame
- 1 and 6 months after the end of treatment.
- description
- The primary outcome measure will be abstinence at 1 month (physical consultation or telephone follow-up) and at 6 months after the end of treatment.
Secondary outcomes (6)
- measure
- Proportion of patients willing to attend a smoking cessation consultation
- timeFrame
- At the 1-month telephone follow-up after the end of treatment.
- description
- Evaluation of patients willing to attend a smoking cessation consultation (assessed among active smokers at the phone follow-up consultation).
- measure
- Abstinence at 1 month after the end of treatment
- timeFrame
- 1 month after the end of treatment
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria : * Patient aged 18 years or older * Diagnosed with head and neck cancer or lung cancer * Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy * Current or former smoker * Patient covered by a social security scheme * Patient informed and having given consent for data collection Patients with human papillomavirus (HPV) may also be included Exclusion Criteria : * Patient receiving palliative treatment * Patient under guardianship or curatorship Study Exit Criteria : \- Protocol-defined exit : After the 12-month consultation Early exit : * Withdrawal of consent for data collection * Death of the patient
References
Publications (0)
Data not yet available